Alam Kamran 4
4 · Taysha Gene Therapies, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-01-02+590,413→ 842,225 total - Award
Employee Stock Option (right to buy)
2024-01-02+590,413→ 590,413 totalExercise: $1.71Exp: 2034-01-02→ Common Stock (590,413 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 2, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.
- [F2]25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2025 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.